CHU Lyon, Hospital Edouard Herriot

Lyon 69437

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia

Studies at this site

• A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia — Completed